FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2141559096> ?p ?o ?g. }

• W2141559096 endingPage "407" @default.
• W2141559096 startingPage "400" @default.
• W2141559096 abstract "Leprosy, a spectral disease manifested on the basis of host immune responses,is complicated by its reactional stages, namely type I reversal reaction (RR)and type II erythema nodosum leprosum (ENL). These reactional stagesare characterized by uncontrolled and aberrant immune responses. Biomarkersfor reactional stages would aid in early diagnosis, efficient treatment, preventionof neurological complications and prediction of predisposition to reactionalstages. In this study, comparative analysis of the serum proteome of leprosypatients by two-dimensional electrophoresis (2DE) followed by massspectrometry showed differential expression of acute-phase protein α 1 -acid glycoprotein (AGP; also known as orosomucoid).AGP levels in untreated ENL cases were significantly higher than in lepromatousleprosy (LL; a non-reactional disease stage) ( P =0.0126),RR ( P =0.0176) and healthy controls ( P =0.0030).These data were confirmed using ELISA. The levels of AGP decreased to normallevels after treatment with multidrug therapy and thalidomide ( P =0.0167). In a follow-up study, AGP levels, which were highin the untreated ENL stage, decreased significantly at 5 days ( P =0.0084) and 21 days ( P =0.0027)post-treatment. A stage-dependent increase in AGP in an LL patient who progressedinto the ENL stage was also shown. Glycosylation analysis by 2DE showed differentialexpression of acidic glycoforms of AGP in untreated ENL cases. Changes inAGP concentration and differential expression of isoforms correlated withthe inflammatory condition in ENL and also with the treatment regimen. Thus,initial validation of AGP as an ENL-specific biomarker and treatment indicatorwas shown in this study." @default.
• W2141559096 created "2016-06-24" @default.
• W2141559096 creator A5037081091 @default.
• W2141559096 creator A5050597103 @default.
• W2141559096 creator A5054750734 @default.
• W2141559096 date "2010-04-01" @default.
• W2141559096 modified "2023-10-17" @default.
• W2141559096 title "α 1-Acid glycoprotein as a putative biomarkerfor monitoring the development of the type II reactional stage of leprosy" @default.
• W2141559096 cites W1555491638 @default.
• W2141559096 cites W1571091964 @default.
• W2141559096 cites W1592573044 @default.
• W2141559096 cites W174186726 @default.
• W2141559096 cites W1800564915 @default.
• W2141559096 cites W1950328332 @default.
• W2141559096 cites W1950677051 @default.
• W2141559096 cites W1966333025 @default.
• W2141559096 cites W1966426785 @default.
• W2141559096 cites W1976213001 @default.
• W2141559096 cites W1987525830 @default.
• W2141559096 cites W1998867226 @default.
• W2141559096 cites W2005447015 @default.
• W2141559096 cites W2010637514 @default.
• W2141559096 cites W2013829288 @default.
• W2141559096 cites W2014683499 @default.
• W2141559096 cites W2014718560 @default.
• W2141559096 cites W2015359420 @default.
• W2141559096 cites W2021859041 @default.
• W2141559096 cites W2038712224 @default.
• W2141559096 cites W2040396472 @default.
• W2141559096 cites W2046622438 @default.
• W2141559096 cites W2046726975 @default.
• W2141559096 cites W2048141239 @default.
• W2141559096 cites W2052668460 @default.
• W2141559096 cites W2070803668 @default.
• W2141559096 cites W2079418606 @default.
• W2141559096 cites W2092108889 @default.
• W2141559096 cites W2094283382 @default.
• W2141559096 cites W2094974766 @default.
• W2141559096 cites W2111816511 @default.
• W2141559096 cites W2119707468 @default.
• W2141559096 cites W2142677908 @default.
• W2141559096 cites W2143877526 @default.
• W2141559096 cites W2151510369 @default.
• W2141559096 cites W2159367931 @default.
• W2141559096 cites W2183480437 @default.
• W2141559096 cites W2512501452 @default.
• W2141559096 cites W4293247451 @default.
• W2141559096 doi "https://doi.org/10.1099/jmm.0.016394-0" @default.
• W2141559096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20075114" @default.
• W2141559096 hasPublicationYear "2010" @default.
• W2141559096 type Work @default.
• W2141559096 sameAs 2141559096 @default.
• W2141559096 citedByCount "21" @default.
• W2141559096 countsByYear W21415590962012 @default.
• W2141559096 countsByYear W21415590962013 @default.
• W2141559096 countsByYear W21415590962015 @default.
• W2141559096 countsByYear W21415590962016 @default.
• W2141559096 countsByYear W21415590962019 @default.
• W2141559096 countsByYear W21415590962020 @default.
• W2141559096 countsByYear W21415590962021 @default.
• W2141559096 countsByYear W21415590962023 @default.
• W2141559096 crossrefType "journal-article" @default.
• W2141559096 hasAuthorship W2141559096A5037081091 @default.
• W2141559096 hasAuthorship W2141559096A5050597103 @default.
• W2141559096 hasAuthorship W2141559096A5054750734 @default.
• W2141559096 hasBestOaLocation W21415590961 @default.
• W2141559096 hasConcept C108625454 @default.
• W2141559096 hasConcept C126322002 @default.
• W2141559096 hasConcept C185592680 @default.
• W2141559096 hasConcept C203014093 @default.
• W2141559096 hasConcept C2776364478 @default.
• W2141559096 hasConcept C2776914184 @default.
• W2141559096 hasConcept C2777410594 @default.
• W2141559096 hasConcept C2779134260 @default.
• W2141559096 hasConcept C2779609412 @default.
• W2141559096 hasConcept C2779846462 @default.
• W2141559096 hasConcept C2780695269 @default.
• W2141559096 hasConcept C2781197716 @default.
• W2141559096 hasConcept C30787643 @default.
• W2141559096 hasConcept C55493867 @default.
• W2141559096 hasConcept C57194454 @default.
• W2141559096 hasConcept C71924100 @default.
• W2141559096 hasConcept C8891405 @default.
• W2141559096 hasConceptScore W2141559096C108625454 @default.
• W2141559096 hasConceptScore W2141559096C126322002 @default.
• W2141559096 hasConceptScore W2141559096C185592680 @default.
• W2141559096 hasConceptScore W2141559096C203014093 @default.
• W2141559096 hasConceptScore W2141559096C2776364478 @default.
• W2141559096 hasConceptScore W2141559096C2776914184 @default.
• W2141559096 hasConceptScore W2141559096C2777410594 @default.
• W2141559096 hasConceptScore W2141559096C2779134260 @default.
• W2141559096 hasConceptScore W2141559096C2779609412 @default.
• W2141559096 hasConceptScore W2141559096C2779846462 @default.
• W2141559096 hasConceptScore W2141559096C2780695269 @default.
• W2141559096 hasConceptScore W2141559096C2781197716 @default.
• W2141559096 hasConceptScore W2141559096C30787643 @default.
• W2141559096 hasConceptScore W2141559096C55493867 @default.
• W2141559096 hasConceptScore W2141559096C57194454 @default.

• next